Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2014-06-02 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Appendix 3B 11 pages 308.4KB
Regulatory Filings
2014-06-02 English
Appointment of Chief Financial Officer 1 page 107.6
Board/Management Information Classification · 100% confidence The document is an announcement dated 29 May 2014 from Genetic Technologies Limited about the appointment of a new Chief Financial Officer. It contains no financial data, no report or presentation, and no mention of voting results or regulatory filings. The content is focused solely on management change. The document length is 3386 characters, which is relatively short and consistent with a management change announcement. Therefore, the document fits best under the category of Board/Management Information (MANG).
2014-05-28 English
ASIC Form 484 4 pages 184.2KB
Regulatory Filings
2014-05-27 English
Change in substantial holding 2 pages 55.2KB
Regulatory Filings
2014-05-22 English
Completion of share transactions with Dr. Mervyn Jacobson 5 pages 206.4KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 16 May 2014 regarding the completion of share transactions involving the company's largest beneficial shareholder, Dr. Mervyn Jacobson. It details the exchange of shares, option agreements, payment of option fees, and the resulting shareholding percentages. The document also includes an Appendix 3C, which is a formal announcement of a selective share buy-back and cancellation of shares, including details about the buy-back type, shares involved, shareholder approval, and compliance statements. The content focuses on capital structure changes, share buy-back, and related transactions rather than financial results, management changes, or regulatory certifications. The presence of the Appendix 3C, a standard ASX form for buy-back announcements, confirms this is a capital/financing update. The document length is over 10,000 characters and contains substantive transaction details, so it is not merely a report publication announcement or a regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2014-05-15 English
Quarterly Reports - 31 March 2014 11 pages 114.6KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 March 2014' and contains detailed operational, financial, licensing, IP, corporate matters, and convertible notes information for the quarter ended 31 March 2014. It includes substantive financial data such as cash receipts, revenue growth, and convertible note conversions, as well as detailed business updates and legal proceedings. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of quarterly financial data and operational analysis aligns with the definition of an Interim / Quarterly Report (IR). It is not a mere announcement or certification, nor is it a full annual report or earnings release. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2014
2014-04-29 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.